AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 271 min read$BMRA

BARBIERI ALLEN purchased $32K of BMRA

BARBIERI ALLEN (Executive Vice Chairman) purchased 20,000 shares of BIOMERICA INC (BMRA) at $1.60 on 2026-08-26.

Original reporting
SEC EDGAR · BARBIERI ALLEN
Published Aug 27, 2026, 9:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 10:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$BMRA
Neutral
medium confidence
Mentioned
$BMRA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BMRANeutralLow
01

Why it matters

The purchase is modest and unlikely to affect BMRA's stock price significantly.

02

Market read

Routine insider buy with limited trading relevance.

03

What to watch

Potential upcoming corporate actions or clinical data not disclosed.

Relevance 4/10Novelty 4/10Timing: filing date 2026-08-27

Background

Form 4 filings disclose insider trades; investors watch for material purchases.

Company-level read

Ticker impact

$BMRANeutralMedium confidence
Context

Executive Vice Chairman Allen bought 20,000 shares for $32,000, raising his stake to 73,542 shares.

Expected impact

Limited short-term impact; may provide slight bullish bias.

Evidence & confidence

Purchase amount is low relative to market cap; unlikely to move price materially.

Market effects

Sector

Minor signal for biotech insider activity; no sector-wide impact.

Regional

U.S. market only; no broader regional effect.

Global

Low

Counterpoint

What could challenge this read

Insider purchase could be routine portfolio rebalancing, not a strong buy signal.

Key entities

  • Executive
    Barbieri Allen

    Executive Vice Chairman of Biomerca Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BMRA insider trading history →

Related articles

MAY 28
$BMRAMedAI 9/10

Biomerica Wins $1.75M Contract to Develop Diagnostic Tests

Biomerica Inc. said it was selected for a $1.75 million master services agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The three-year work will be performed at Biomerica’s Irvine facility, according to the company. Biomerica said the initial fees provide near-term revenue visibility. Shares fell 2.2% to $2.40.

ocbj.com3 min